FOUNDERS CAPITAL MANAGEMENT, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
FOUNDERS CAPITAL MANAGEMENT, LLC portfolio value:
$5.85M
portfolio value
FOUNDERS CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.23% | -106 shares | 769K | $688.87 | 8.50K |
Q2 2022 | share | Increase | +0.28% | 24 shares | -907K | $591.13 | 8.61K |
Q1 2022 | share | Increase | +0.99% | 84 shares | 627K | $698.42 | 8.58K |
Q4 2021 | share | Decrease | -3.36% | -296 shares | 45K | $642.51 | 8.50K |
Q3 2021 | share | Decrease | -1.37% | -122 shares | 342K | $605.18 | 8.79K |
Q2 2021 | share | Increase | +127.58% | 5.00K shares | 3.12M | $558.54 | 8.92K |
Q1 2021 | share | Increase | +579.38% | 3.34K shares | 1.57M | $473.14 | 3.92K |
Q4 2020 | share | 0.00% | 0 shares | -44K | $483.11 | 577 | |
Q3 2020 | share | 0.00% | 0 shares | -37K | $559.78 | 577 | |
Q2 2020 | share | 0.00% | 0 shares | 78K | $623.65 | 577 | |
Q1 2020 | share | 0.00% | 0 shares | 65K | $488.29 | 577 | |
Q4 2019 | share | 0.00% | 0 shares | 54K | $375.48 | 577 | |
Q3 2019 | share | 0.00% | 0 shares | -18K | $277.4 | 577 | |
Q2 2019 | share | 0.00% | 0 shares | -56K | $313 | 577 | |
Q1 2019 | share | 0.00% | 0 shares | 21K | $410.62 | 577 | |
Q4 2018 | share | 0.00% | 0 shares | -10K | $373.5 | 577 | |
Q3 2018 | share | Increase | 0.00% | 577 shares | 226K | $404.04 | 577 |
Q1 2018 | share | Decrease | -100.00% | -577 shares | -217K | $344.36 | 0 |
Q4 2017 | share | 0.00% | 0 shares | -41K | $375.96 | 577 | |
Q3 2017 | share | Decrease | -14.77% | -100 shares | -75K | $447.12 | 577 |
Q2 2017 | share | 0.00% | 0 shares | 71K | $491.14 | 677 | |
Q1 2017 | share | 0.00% | 0 shares | 13K | $387.51 | 677 | |
Q4 2016 | share | 0.00% | 0 shares | -23K | $367.09 | 677 | |
Q3 2016 | share | 0.00% | 0 shares | 36K | $402.02 | 677 | |
Q2 2016 | share | 0.00% | 0 shares | -8K | $349.23 | 677 | |
Q1 2016 | share | 0.00% | 0 shares | -124K | $360.44 | 677 |